You are here: Home

 Welcome to Elite Pharmaceuticals

 
 

Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tablets, pellets, capsules, granules and powders.  The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

 
       Click here to be directed to Elite's 2014 Annual Meeting Information

 


Recent Press Releases:
8/14/2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015 Revenues Increase by 61%, Product Development on Schedule Conference Call Scheduled for Monday, August 18th at 11:00 AM EDT

8/13/2014 Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014 ….First Quarter Financials for Fiscal Year 2015 Are Scheduled To Be Filed on Thursday, August 14, 2014

7/15/2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for ELI-201

6/30/2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014
Revenues Increase by 35%, Product Development Accelerating
Conference Call Scheduled for Tuesday, July 1 at 12:00 PM EDT


6/10/2014 Elite Pharmaceuticals Enters Into $5 Million Settlement Agreement with Novel Laboratories

 

Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com